Krystal Biotech (NASDAQ:KRYS) Price Target Raised to $240.00 at HC Wainwright
Krystal Biotech (NASDAQ:KRYS – Get Free Report) had its price target raised by HC Wainwright from $221.00 to $240.00 in a research report issued on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. HC Wainwright’s price target would suggest a potential upside of 40.70% from the stock’s previous close. KRYS has […]
